U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07200479) titled 'A Clinical Study to Explore CT1194D in Patients With Relapsed/Refractory B-Cell Neoplasms' on Sept. 19.
Brief Summary: A Clinical Study to Explore the Safety, Efficacy and Cellular Metabolic Kinetics of CT1194D CAR-T Cells Injection in Patients with Relapsed/Refractory B-Cell Neoplasms
Study Start Date: Oct. 30
Study Type: INTERVENTIONAL
Condition:
Relapsed/Refractory B-Cell Neoplasms
Intervention:
DRUG: CAR T cells chimeric antigen receptor cells
CT1194D cells infusion
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Published by HT Digital Content Services with permi...